| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | HKEX Exchange | G98961108 CUSIP |
| China Country | 2,488 Employees | - Last Dividend | - Last Split | - IPO Date |
Zhongzhi Pharmaceutical Holdings Limited is a prominent player in the pharmaceutical industry within the People’s Republic of China, engaging in an extensive range of business activities. Founded in 1993 and based in Zhongshan, the company has positioned itself as a leader in the research, development, manufacture, and sale of pharmaceutical products. Operating under two main segments, Pharmaceutical Manufacturing and Operation of Chain Pharmacies, the company offers an array of Chinese patent medicines, food, Chinese herbs, alongside providing detection, testing, and property management services. It operates as a subsidiary under the Crystal Talent Investment Group Limited, showcasing its robust backing and strategic partnership within the industry.
Under the respected brands Zeus, Liumian, and Caojinghua, the company manufactures and markets a wide variety of Chinese patent medicines and decoction pieces. These products are rooted in traditional Chinese medicine practices, formulated to meet the health and wellness needs of their consumers.
In addition to pharmaceutical products, Zhongzhi Pharmaceutical also engages in the manufacture and sale of food items and Chinese herbs. This diversification into related health and wellness sectors allows the company to offer a broader spectrum of products to its customers, leveraging the natural and medicinal properties of herbs in their offerings.
The company extends its expertise to detection and testing services, providing essential quality assurance for its products and related industries. This sector ensures the efficacy and safety of pharmaceuticals, food items, and herbs, reinforcing the company’s commitment to high standards and consumer trust.
Beyond its core pharmaceutical and health-related services, Zhongzhi Pharmaceutical Holdings Limited also partakes in property management. This division of the company underscores its diverse capabilities and strategic initiatives to leverage its assets for additional revenue streams and operational efficiency.